肾移植受者居家自测肾功能的可行性与结果一致性研究
STOK 前瞻性单中心可行性研究纳入 15 例稳定期肾移植受者,比较居家自测(Abbott i-STAT Alinity 分析仪测毛细血管血)与门诊标准检测(Siemens Advia Chemistry XPT 分析仪测静脉血)的肌酐和血钾一致性。肌酐组内平均差 2.25 μmol/l(95%CI -12.13, 16.81),血钾组内平均差 0.66 mmol/l(95%CI -1.47, 2.79);全部肌酐配对和 27/40(67.5%)血钾配对判定为临床等效。结论认为培训后患者居家自测肌酐与标准检测一致性好,血钾一致性较差。
要点
- 稳定期肾移植受者经培训后可用手持设备居家自测肾功能。
- 自测肌酐与门诊标准检测分析及临床一致性良好。
- 自测血钾与标准检测一致性较差,但患者居家使用 i-STAT 非配对血钾差异的统计学显著来源。
核心结论
- 这项小型可行性研究观察到,培训选定患者使其能熟练使用手持设备在家自测肾功能是可行的。
- 自测肌酐结果与门诊标准检测结果在分析和临床上均显示良好一致性。
- 自测血钾结果与门诊标准检测结果一致性较差,但患者居家使用 i-STAT 并非配对血钾检测结果差异的统计学显著来源。
研究设计与样本
- 前瞻性、观察性、单中心临床可行性研究(注册号 ISRCTN68116915),纳入 15 例稳定期肾移植受者。
- 比较居家自测(患者用 Abbott i-STAT Alinity 分析仪测毛细血管血)与门诊参考检测(工作人员采静脉血,用实验室 Siemens Advia Chemistry XPT 分析仪检测)的血钾和肌酐结果一致性。
- 采用 Bland-Altman 分析和误差网格分析评估一致性。
主要发现
- 肌酐的组内平均差为 2.25 μmol/l(95%CI -12.13, 16.81 μmol/l)。
- 血钾的组内平均差为 0.66 mmol/l(95%CI -1.47, 2.79 mmol/l)。
- 全部肌酐配对和 27/40(67.5%)血钾配对判定为临床等效。
- 计划性随访分析提示,与毛细血管血钾测定相关的生化变量是配对检测结果差异的主要来源。
- 患者与护士 i-STAT 毛细血管血钾配对结果无统计学显著差异。
关键数值与推荐
- 肌酐组内平均差 2.25 μmol/l(95%CI -12.13, 16.81 μmol/l)。
- 血钾组内平均差 0.66 mmol/l(95%CI -1.47, 2.79 mmol/l)。
- 27/40(67.5%)血钾配对判定为临床等效;全部肌酐配对判定为临床等效。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文明确表述为小型可行性研究。
- 研究为单中心设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: People with long-term health conditions often attend clinics for kidney function tests. The Self-Testing Own Kidneys (STOK) study assessed feasibility of kidney transplant recipients using hand-held devices to self-test kidney function at home and investigated agreement between home self-test and standard clinic test results. METHODS: A prospective, observational, single-center, clinical feasibility study (TRN: ISRCTN68116915), with N = 15 stable kidney transplant recipients, investigated blood potassium and creatinine results agreement between index self-tests at home (patient self-testing of capillary blood, using Abbott i-STAT Alinity analyzers [i-STAT]) and reference tests in clinic (staff sampled venous blood, analyzed with laboratory Siemens Advia Chemistry XPT analyzer) using Bland-Altman and error grid analysis. RESULTS: The mean within-patient difference between index and reference test in creatinine was 2.25 μmol/l (95% confidence interval [CI]: -12.13, 16.81 μmol/l) and in potassium was 0.66 mmol/l (95% CI: -1.47, 2.79 mmol/l). All creatinine pairs and 27 of 40 (67.5%) potassium pairs were judged clinically equivalent. Planned follow-up analysis suggests that biochemical variables associated with potassium measurement in capillary blood were predominant sources of paired test result differences. Paired patient and nurse i-STAT capillary blood test potassium results were not statistically significantly different. CONCLUSIONS: This small feasibility study observed that training selected patients to competently use hand-held devices to self-test kidney function at home is possible. Self-test creatinine results showed good analytical and clinical agreement with standard clinic test results. Self-test potassium results showed poorer agreement with standard clinic test results; however, patient self-use of i-STATs at home was not a statistically significant source of difference between paired potassium test results.
引用
- Murray JS, Williams CJ, Lendrem C, et al. Patient Self-Testing of Kidney Function at Home, a Prospective Clinical Feasibility Study in Kidney Transplant Recipients. Kidney Int Rep. 2023. PMID: 37284676. doi:10.1016/j.ekir.2023.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。